Vivek Ramaswamy, billionaire and former Republican presidential candidate, is under fire as social media explodes with accusations of financial misconduct. Critics claim Ramaswamy profited massively from a pump-and-dump scheme involving a failed Alzheimer’s drug, leaving investors in financial ruin.

The allegations focus on Ramaswamy’s pharmaceutical company, Roivant Sciences, which was touted as a biotechnology innovator. Instead, detractors argue, the company primarily acted as a financial vehicle. One of its most high-profile projects, Axovant, revolved around an Alzheimer’s drug that Ramaswamy acquired for $5 million. The drug became the cornerstone of a public relations blitz, pushing the company’s valuation to $2.2 billion before its eventual collapse.

Ramaswamy has attempted to deflect criticism by positioning himself as an advocate for STEM education and “meritocracy.” However, his detractors argue his career contradicts these values. One user wrote, “Vivek Ramaswamy scammed $2 billion with a failed Alzheimer’s drug and is now lecturing Americans on how hardworking Indians are. I urge Donald Trump to open an investigation and deport him to India.”